Paola Di Carlo | Medicine and Health Sciences | Best Review Paper Award

Best Review Paper Award

Paola Di Carlo
University of Palermo, Italy

Paola Di Carlo
Affiliation University of Palermo, IT
Country Italy
Scopus ID 6604018676
Documents 147
Citations 2368
h-index 25
Subject Area Medicine and Health Sciences
Event International Environmental Scientists Award
ORCID 0000-0003-4418-5855

Paola Di Carlo is an Italian researcher affiliated with the University of Palermo whose scientific work spans microbiology, infectious diseases, microbiome research, nanomedicine, antimicrobial resistance, and translational medicine. Through a substantial publication record and multidisciplinary collaborations, she has contributed to the advancement of knowledge concerning microbial ecology, cancer-related microbiota, respiratory infections, and innovative therapeutic strategies. Her scholarly profile demonstrates sustained engagement with emerging topics in medicine and health sciences, making her a notable candidate for recognition through the Best Review Paper Award within the International Environmental Scientists Award program.[1]

Abstract

This article reviews the academic profile, publication achievements, and scientific contributions of Paola Di Carlo. Her research portfolio reflects a strong commitment to understanding microbiological processes involved in human disease, including microbiome dysbiosis, antimicrobial resistance, respiratory pathogens, and cancer-associated microbial ecosystems. Recent publications emphasize review-based synthesis of emerging evidence and provide clinically relevant perspectives for researchers and healthcare professionals.[2]

Keywords

Microbiome Research, Antimicrobial Resistance, Infectious Diseases, Nanomedicine, Biliary Cancer, Translational Medicine, Clinical Microbiology, Review Articles, Medical Sciences, Evidence Synthesis.

Introduction

Modern biomedical research increasingly relies on interdisciplinary approaches that integrate microbiology, clinical medicine, molecular biology, and public health. Within this landscape, Paola Di Carlo has developed a research portfolio characterized by scientific rigor and relevance to contemporary healthcare challenges. Her publications explore the relationship between microbial communities and disease progression, while also assessing therapeutic innovations and preventive strategies.[3]

Research Profile

With 147 indexed publications, 2,368 citations, and an h-index of 25, Di Carlo has established a substantial scholarly presence within medicine and health sciences. Her work frequently addresses microbiological determinants of disease, antimicrobial stewardship, pathogen surveillance, and microbiome-mediated mechanisms. The breadth of her research demonstrates both clinical relevance and translational value across multiple healthcare domains.[1]

Research Contributions

  • Investigation of microbiome dysbiosis and its implications for cancer development and therapeutic interventions.
  • Research on multidrug-resistant pathogens and innovative antimicrobial approaches.
  • Evaluation of lipid nanoparticle systems to enhance antibiofilm activity and drug delivery.
  • Clinical studies involving Legionella pneumophila infections and epidemiological assessment.
  • Comprehensive review articles synthesizing current evidence on biliary and pancreatic tract diseases.

Publications

  • Polyphenols and ADPKD: A Further Aid from Nature? Life (2026).
  • Biliary Tract and Pancreatic Cancer (BTPC) in Adult Patients: The Role of the Biliary Microbiota in Cancer and Therapeutic Strategies—A Scoping Review. Cancers (2026).
  • Multicomponent Lipid Nanoparticles as a Tool to Potentially Improve the Antibiofilm Activity of Resveratrol against MDR Clinical Isolates. ACS Omega (2026).
  • Microbiome Dysbiosis, Chemoprophylaxis, and Tumor Microenvironment in Biliary–Pancreatic Tract Diseases.
  • Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024. Pathogens (2025).

Research Impact

The impact of Di Carlo’s research is reflected through consistent citation activity, interdisciplinary collaborations, and publication in internationally recognized journals. Her review articles provide valuable syntheses of emerging evidence, enabling clinicians and researchers to better understand disease mechanisms and potential treatment pathways. Such contributions support evidence-based healthcare decision-making and stimulate future research initiatives.[4]

Award Suitability

Paola Di Carlo demonstrates qualities commonly associated with recipients of review-focused academic distinctions. Her ability to consolidate complex scientific evidence, identify knowledge gaps, and communicate research findings in accessible scholarly formats contributes significantly to the advancement of medicine and health sciences. The depth and relevance of her recent review publications align strongly with the objectives of the Best Review Paper Award.[5]

Conclusion

Paola Di Carlo has developed a distinguished academic record characterized by productive scholarship, interdisciplinary engagement, and meaningful contributions to microbiology and medical research. Her publication portfolio, citation impact, and emphasis on comprehensive review-based scholarship provide a strong foundation for recognition within international scientific award programs. The available evidence supports her suitability for acknowledgment through the Best Review Paper Award.

References

  1. Elsevier. (n.d.). Scopus author details: Paola Di Carlo, Author ID 6604018676. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6604018676
  2. Di Carlo, P. et al. (2026). Polyphenols and ADPKD: A Further Aid from Nature? Life.
    https://doi.org/10.3390/life16061022
  3. Di Carlo, P. et al. (2026). Biliary Tract and Pancreatic Cancer in Adult Patients: A Scoping Review. Cancers.
    https://doi.org/10.3390/cancers18121875
  4. Di Carlo, P. et al. (2026). Multicomponent Lipid Nanoparticles and Antibiofilm Activity. ACS Omega.
    https://doi.org/10.1021/acsomega.5c12649
  5. Di Carlo, P. (2026). Microbiome Dysbiosis, Chemoprophylaxis, and Tumor Microenvironment in Biliary–Pancreatic Tract Diseases. OSF.
    https://doi.org/10.17605/osf.io/uc34p
  6. Di Carlo, P. et al. (2025). Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024. Pathogens.
    https://doi.org/10.3390/pathogens15010013

George Vaos | Medicine | Stellar Contributions to Science Award

Prof. Dr. George Vaos | Medicine | Stellar Contributions to Science Award

Prof. Dr. George Vaos | Medicine | National and Kapodistrian University of Athens | Greece

Prof. Dr. George Vaos is an internationally recognized male academic and clinician whose scholarly and professional contributions have significantly advanced pediatric surgery and its intersections with public health, clinical epidemiology, and evidence-based medical science. His educational background includes comprehensive medical training followed by advanced doctoral-level education at a prestigious European university, where he developed a strong foundation in surgical sciences, clinical research methodology, and translational medicine, later complemented by continuous academic development within leading medical institutions.

Citation Metrics (Google Scholar)

2500

2000

1500

1000

500

0

.

Citations
1817
i10index
43

h-index
24

                  🟦 Citations      🟥 i10index          🟩 h-index

View Google Scholar Profile

Featured Publications:

Multicenter Assessment of Ultrasound of the Spermatic Cord in Children with Acute Scrotum

– The Journal of Urology, 2007 · 254 Citations
Fecal Calprotectin in Pediatric Inflammatory Bowel Disease: A Systematic Review

– Digestive Diseases and Sciences, 2013 · 113 Citations
The Role of Calprotectin in Pediatric Disease

– BioMed Research International, 2013 · 108 Citations
Optimal Timing for Repair of an Inguinal Hernia in Premature Infants

– Pediatric Surgery International, 2010 · 88 Citations
Immediate Surgery or Conservative Treatment for Complicated Acute Appendicitis in Children? A Meta-Analysis

– Journal of Pediatric Surgery, 2019 · 81 Citations

 

Velimir Altabas | Human Medicine | Best Researcher Award

Assist. Prof. Dr. Velimir Altabas | Human Medicine | Best Researcher Award

Head of Outpatient Clinic, University of Zagreb, Croatia.

Dr. Velimir Altabas is a Croatian physician and researcher. With a profound dedication to internal medicine, endocrinology, and metabolic diseases, he has spent over three decades blending clinical practice, academic teaching, and impactful research. He is an Assistant Professor at the Medical Faculty of the University of Zagreb and heads the Outpatient Clinic and Day Hospital at the Institute of Endocrinology, Diabetes and Metabolic Diseases, “Sestre Milosrdnice” University Hospital. Married to Dr. Karmela Altabas and father of two, he is deeply rooted in both family and science. His contributions have earned international recognition, including being named among the world’s top 2% scientists by Stanford/Elsevier in 2019 and 2022. Dr. Altabas continues to influence the field through research, education, and active roles in Croatian medical societies.

Profile

Scopus

ORCID

🎓 Education

Dr. Velimir Altabas began his education in Germany and Croatia, culminating in a medical degree from the University of Zagreb in 1994. He completed clinical internships in Hamburg, Germany (1991), and São Paulo, Brazil (1993), enriching his global clinical exposure. He earned a Master’s in internal medicine in 2005 with a thesis on thyamazole’s effects on bone metabolism, and a PhD in 2011 on stress hyperglycaemia’s impact on myocardial infarction outcomes. His postgraduate training in clinical pharmacology and additional clinical education in Germany reflect his commitment to continuous learning. His solid academic foundation underpins a multidisciplinary career in endocrinology, cardiology, and metabolic medicine.

🩺 Experience

Dr. Altabas’s professional journey began at Dubrava Clinical Hospital, followed by significant roles at the “Sestre Milosrdnice” University Clinical Hospital. From residency to specialist in internal medicine and eventually subspecialist in endocrinology, he steadily rose through ranks. He has served as a teacher, senior assistant, and now assistant professor at the University of Zagreb. His administrative leadership includes directing the Outpatient Clinic and Day Hospital. Additionally, he held influential positions in national medical societies, such as Vice President of the Croatian Society for Diabetes and Metabolic Diseases and Treasurer of the Croatian Endocrine Society. His clinical and academic experience bridges theory and practice seamlessly.

🔬 Research Interest

Dr. Altabas’s research is centered on endocrinology, diabetology, and cardiometabolic health, with particular focus on the intersection of metabolic disorders and cardiovascular outcomes. His doctoral thesis explored the role of stress hyperglycaemia in non-diabetic patients with acute myocardial infarction—a topic with high clinical relevance. He has also investigated bone metabolism in hyperthyroid women, reflecting his interest in hormone-related systemic effects. His studies often examine how metabolic dysfunction influences broader disease processes, helping refine diagnostic and treatment pathways. A clinician-researcher at heart, Dr. Altabas aims to bridge research findings with bedside application. He collaborates within multidisciplinary teams and contributes to the body of knowledge that informs Croatian and international guidelines in endocrinology.

🏆 Awards and Honors

Dr. Velimir Altabas has received notable recognition for his contributions to science and medicine. Most significantly, he was listed among the world’s top 2% of scientists by Stanford University and Elsevier for the years 2019 and 2022, a reflection of his research excellence and impact. These distinctions are based on citation metrics, underscoring his global relevance in endocrinology and metabolic disease research. In addition to academic accolades, he has earned respect within Croatia’s medical community through leadership roles in endocrine and diabetes societies. His reputation is built on years of consistent scholarly output, teaching excellence, and clinical advancement.

📚 Publications

Flash Glucose Monitoring for Predicting Cardiogenic Shock Occurrence in Critically Ill Patients: A Retrospective Pilot Study
Authors: Velimir Altabas, Dorijan Babić, Anja Grulović, Tomislav Bulum, Zdravko Babić
Year: 2025
Journal: Diagnostic

Current Challenges in Pancreas and Islet Transplantation: A Scoping Review
Authors: Velimir Altabas, Tomislav Bulum
Year: 2025
Citations: 1

Technology Beyond Biology; Isn’t It Time to Update WHO’s Definition of Health?
Authors: Maja Baretić, Dragan Primorac, David de Bruijn, Velimir Altabas
Year: 2024
Journal: Medicina (Kaunas, Lithuania)

Referrals for Gender-Affirming Hormone Treatment in Croatia’s National Network for Transgender Healthcare
Authors: Velimir Altabas, Vesna Galjuf, Iva Žegura, Goran Arbanas, Dražen Begić
Year: 2024
Journal: Archives of Sexual Behavior

🏁 Conclusion

Dr. Velimir Altabas is highly deserving of serious consideration for the Best Researcher Award, particularly given his long-standing contributions to endocrinology and internal medicine, his academic involvement, and his recognition among the top 2% of scientists worldwide. However, to strengthen his candidacy further, it would be beneficial to include more quantitative research metrics, details on publications, and evidence of research funding or innovation. Despite these gaps, his career reflects a solid and impactful research trajectory deserving of high regard.